Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Apr;51(4):506–509. doi: 10.1136/ard.51.4.506

Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome.

A Hietaharju 1, M Korpela 1, J Ilonen 1, H Frey 1
PMCID: PMC1004702  PMID: 1586250

Abstract

Twenty seven patients with primary or possible Sjögren's syndrome with neurological manifestations were compared immunologically with 21 patients with Sjögren's syndrome with an intact nervous system. Patients with Sjögren's syndrome were divided into seropositive and seronegative subgroups with respect to the occurrence of one or more autoantibodies (antinuclear antibodies, rheumatoid factor, antibodies to SS-B) in their serum samples. This study of 48 patients indicates that the spectrum of nervous system disease in seronegative and seropositive subgroups is almost indistinguishable. No significant differences were found in the occurrence of circulating immune complexes, the levels of serum complement C3 and C4, or serum IgA, IgM, and beta 2 microglobulin with respect to the neurological manifestations. The serum IgG level, however, was significantly higher in the patients with Sjögren's syndrome with intact nervous systems than in those with neurological manifestations. No significant association was found between the HLA phenotype and nervous system disease. The occurrence of HLA-B8 and DR3 antigens was, however, significantly higher in those patients with antibodies to SS-B than in those without. This finding supports the suggestion that HLA-B8/DR3 may modulate autoantibody responses rather than disease expression in Sjögren's syndrome.

Full text

PDF
506

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATTWOOD W., POSER C. M. Neurologic complications of Sjogren's syndrome. Neurology. 1961 Dec;11:1034–1041. doi: 10.1212/wnl.11.12.1034. [DOI] [PubMed] [Google Scholar]
  2. Alexander E. L., Hirsch T. J., Arnett F. C., Provost T. T., Stevens M. B. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol. 1982 Mar-Apr;9(2):239–246. [PubMed] [Google Scholar]
  3. Alexander E. L., Malinow K., Lejewski J. E., Jerdan M. S., Provost T. T., Alexander G. E. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med. 1986 Mar;104(3):323–330. doi: 10.7326/0003-4819-104-3-323. [DOI] [PubMed] [Google Scholar]
  4. Alspaugh M. A., Buchanan W. W., Whaley K. Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis, and other organ and nonorgan-specific autoimmune diseases. Ann Rheum Dis. 1978 Jun;37(3):244–246. doi: 10.1136/ard.37.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Andonopoulos A. P., Lagos G., Drosos A. A., Moutsopoulos H. M. The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol. 1990 Feb;29(1):21–23. doi: 10.1093/rheumatology/29.1.21. [DOI] [PubMed] [Google Scholar]
  6. Binder A., Snaith M. L., Isenberg D. Sjögren's syndrome: a study of its neurological complications. Br J Rheumatol. 1988 Aug;27(4):275–280. doi: 10.1093/rheumatology/27.4.275. [DOI] [PubMed] [Google Scholar]
  7. Chused T. M., Kassan S. S., Opelz G., Moutsopoulos H. M., Terasaki P. I. Sjögren's syndrome association with HLA-Dw3. N Engl J Med. 1977 Apr 21;296(16):895–897. doi: 10.1056/NEJM197704212961602. [DOI] [PubMed] [Google Scholar]
  8. Clough J. D., Aponte C. J., Braun W. E. HLA-B8 and clinical features of Sjogren's syndrome. Clin Immunol Immunopathol. 1977 May;7(3):324–329. doi: 10.1016/0090-1229(77)90065-4. [DOI] [PubMed] [Google Scholar]
  9. Fox R. I., Robinson C., Curd J., Michelson P., Bone R., Howell F. V. First international symposium on Sjögren's syndrome: suggested criteria for classification. Scand J Rheumatol Suppl. 1986;61:28–30. [PubMed] [Google Scholar]
  10. Fye K. H., Terasaki P. I., Michalski J. P., Daniels T. E., Opelz G., Talal N. Relationshipp of HLA-Dw3 and HLA-B8 to Sjögren's syndrome. Arthritis Rheum. 1978 Apr;21(3):337–342. doi: 10.1002/art.1780210308. [DOI] [PubMed] [Google Scholar]
  11. Gajdos P., Outin H., Elkharrat D., Brunel D., de Rohan-Chabot P., Raphael J. C., Goulon M., Goulon-Goeau C., Morel E. High-dose intravenous gammaglobulin for myasthenia gravis. Lancet. 1984 Feb 18;1(8373):406–407. doi: 10.1016/s0140-6736(84)90469-0. [DOI] [PubMed] [Google Scholar]
  12. Gershwin M. E., Terasaki I., Graw R., Chused T. M. Increased frequency of HL-A8 in Sjogren's syndrome. Tissue Antigens. 1975 Nov;6(5):342–346. doi: 10.1111/j.1399-0039.1975.tb00653.x. [DOI] [PubMed] [Google Scholar]
  13. Golding P. L., Smith M., Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med. 1973 Dec;55(6):772–782. doi: 10.1016/0002-9343(73)90258-1. [DOI] [PubMed] [Google Scholar]
  14. Hietaharju A., Yli-Kerttula U., Häkkinen V., Frey H. Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand. 1990 Feb;81(2):144–152. doi: 10.1111/j.1600-0404.1990.tb00951.x. [DOI] [PubMed] [Google Scholar]
  15. Kaltreider H. B., Talal N. The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement. Ann Intern Med. 1969 Apr;70(4):751–762. doi: 10.7326/0003-4819-70-4-751. [DOI] [PubMed] [Google Scholar]
  16. Kaplan J. G., Rosenberg R., Reinitz E., Buchbinder S., Schaumburg H. H. Invited review: peripheral neuropathy in Sjogren's syndrome. Muscle Nerve. 1990 Jul;13(7):570–579. doi: 10.1002/mus.880130703. [DOI] [PubMed] [Google Scholar]
  17. Karlish A. J. Lung changes in Sjögren's syndrome. Proc R Soc Med. 1969 Oct;62(10):1042–1043. doi: 10.1177/003591576906201028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lisak R. P., Moore P. M., Levinson A. I., Zweiman B. Neurologic complications of collagen vascular diseases. Ann N Y Acad Sci. 1988;540:115–121. doi: 10.1111/j.1749-6632.1988.tb27057.x. [DOI] [PubMed] [Google Scholar]
  19. Manthorpe R., Morling N., Platz P., Ryder L. P., Svejgaard A., Thomsen M. HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form. Scand J Rheumatol. 1981;10(2):124–128. doi: 10.3109/03009748109095284. [DOI] [PubMed] [Google Scholar]
  20. Melamies L. M., Ruutsalo H. M., Nissilä H. Evaluation of a quantitative immunoturbidimetric assay for rheumatoid factors. Clin Chem. 1986 Oct;32(10):1890–1894. [PubMed] [Google Scholar]
  21. Molina R., Provost T. T., Alexander E. L. Peripheral inflammatory vascular disease in Sjögren's syndrome. Association with nervous system complications. Arthritis Rheum. 1985 Dec;28(12):1341–1347. doi: 10.1002/art.1780281205. [DOI] [PubMed] [Google Scholar]
  22. Molina R., Provost T. T., Arnett F. C., Bias W. B., Hochberg M. C., Wilson R. W., Alexander E. L. Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med. 1986 Jan;80(1):23–31. doi: 10.1016/0002-9343(86)90044-6. [DOI] [PubMed] [Google Scholar]
  23. Moore P. M., Lisak R. P. Multiple sclerosis and Sjögren's syndrome: a problem in diagnosis or in definition of two disorders of unknown etiology? Ann Neurol. 1990 May;27(5):585–586. doi: 10.1002/ana.410270523. [DOI] [PubMed] [Google Scholar]
  24. Pease C. T., Shattles W., Charles P. J., Venables P. J., Maini R. N. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome. Clin Exp Rheumatol. 1989 Mar-Apr;7(2):185–190. [PubMed] [Google Scholar]
  25. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  26. Roifman C. M., Schaffer F. M., Wachsmuth S. E., Murphy G., Gelfand E. W. Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA. 1987 Jul 24;258(4):513–515. doi: 10.1001/jama.1987.03400040111034. [DOI] [PubMed] [Google Scholar]
  27. SILBERBERG D. H., DRACHMAN D. A. Late-life myopathy occurring with Sjogren's syndrome. Arch Neurol. 1962 Jun;6:428–438. doi: 10.1001/archneur.1962.00450240006002. [DOI] [PubMed] [Google Scholar]
  28. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  29. Tu W. H., Shearn M. A., Lee J. C., Hopper J., Jr Interstitial nephritis in Sjögren's syndrome. Ann Intern Med. 1968 Dec;69(6):1163–1170. doi: 10.7326/0003-4819-69-6-1163. [DOI] [PubMed] [Google Scholar]
  30. Zanetti M., Bigazzi P. E. Anti-idiotypic immunity and autoimmunity. I. In vitro and in vivo effects of anti-idiotypic antibodies to spontaneously occurring autoantibodies to rat thyroglobulin. Eur J Immunol. 1981 Mar;11(3):187–195. doi: 10.1002/eji.1830110306. [DOI] [PubMed] [Google Scholar]
  31. Ziola B., Salmi A., Penttinen K. Porcine C1q and the solid-phase immunoassay of human immune complexes. J Immunol Methods. 1982 Mar 26;49(3):247–260. doi: 10.1016/0022-1759(82)90125-9. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES